Evidence map›Paper›PMID 42230726›Full record

ArticleScientific reports2026

Multiplexing antibiotic screening assay in droplet microfluidics.

Sundar Hengoju, Karin Martin, Kirstin Scherlach, Martin Roth, Miriam A Rosenbaum

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sundar HengojuBio Pilot Plant, Leibniz Institute for Natural Product Research and Infection Biology - Hans-Knöll-Institute, 07745, Jena, Germany.
Karin MartinBio Pilot Plant, Leibniz Institute for Natural Product Research and Infection Biology - Hans-Knöll-Institute, 07745, Jena, Germany.
Kirstin ScherlachBiomolecular Chemistry, Leibniz Institute for Natural Product Research and Infection Biology - Hans-Knöll-Institute, 07745, Jena, Germany.
Martin RothBio Pilot Plant, Leibniz Institute for Natural Product Research and Infection Biology - Hans-Knöll-Institute, 07745, Jena, Germany.
Miriam A RosenbaumBio Pilot Plant, Leibniz Institute for Natural Product Research and Infection Biology - Hans-Knöll-Institute, 07745, Jena, Germany. Miriam.rosenbaum@leibniz-hki.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Environmental samples contain complex microbial communities hiding a treasure trove of active compounds. However, screening for active natural products from environmental samples is challenging due to inefficient cultivation techniques and a lack of proper screening platforms. For empowering antibiotic screening assays from complex microbial communities, we have developed and optimized a droplet-based platform with multiplexing capability. A cultivation strategy for bacteria in picoliter droplets was combined with phenotypic screening using multiple whole-cell reporter species. A mixture of two different fluorescently labelled reporter strains, one Gram-positive and one Gram-negative, was picoinjected to each of millions of picoliter cultures, which were screened for inhibiting activity based on the independent survival signals of each reporter species. Proof-of-concept experiments demonstrate efficient detection, selection, and recovery of a model Streptomyces strain from a synthetic mixture according to the specific inhibition of the reporter strains by the produced antibiotic. Subsequently, the established platform was successfully applied to screen environmental microbial communities from soil samples. This approach showcases multiplexing capabilities for screening assays in microfluidic droplets in order to simultaneously screen for new bioactive compounds with various inhibition profiles.

Indexed as

Anti-Bacterial AgentsMicrofluidicsDrug Evaluation, PreclinicalHigh-Throughput Screening AssaysMicrobial Sensitivity TestsStreptomycesAnti-Bacterial AgentsHigh-throughput phenotypic assayNatural product discoveryPicolitre cultivationWhole-cell reporter strains

Identifiers

PMID42230726
PMCPMC13230938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.